Customer Center
Login | Register

A Laboratory’s Perspective: How the University of Louisville Infectious Diseases Lab Leverages Molecular Testing

February 22nd, 2018 / Scott Henderson

Luminex has been out on the road, talking to customers, and capturing videos to help get the word out about how our technology can help empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. Meet the University of Louisville Infectious Diseases Laboratory The University of Louisville Infectious Diseases Laboratory (U of L

Continue reading »

Webinar Wednesday: Mahmoud Elsabahy, PhD, from Texas A&M University

February 21st, 2018 / Hilary Graham

Immunogenicity Profiling of Nanocarriers For our second Webinar Wednesday blog, we’re featuring a talk from Mahmoud Elsabahy who is working to establish a new immunotoxicity index for multiplex data analysis and interpretation. He uses xMAP® Technology to trace the biomarker response to nanomedicines and nanocarriers. Dr. Elsabahy is the Assistant Director of the Laboratory for

Continue reading »

The Faces of Luminex: Audrey Escalante, Lead Technical Applications Trainer

February 16th, 2018 / Christine Valle

Who trains the trainers? At Luminex, the answer is Audrey Escalante, Lead Technical Applications Trainer. A recent transplant to Austin, she earned her bachelor’s degree in chemistry at Illinois State University and her masters of curriculum and instruction at the American College of Education. She joined Luminex in 2015. Q: What are your responsibilities at

Continue reading »

Get to Know xMAP® Technology at the Drug Discovery 2018 Virtual Conference

February 16th, 2018 / Hilary Graham

All of the networking, none of the flu risk We’re pleased to be participating in the upcoming two-day virtual conference, Drug Discovery 2018, hosted by LabRoots starting February 21st. If you’ve never attended a virtual conference before, think of it as an opportunity to engage in all the great scientific education, technology updates, and networking

Continue reading »

Shifting STI Landscape Puts Pressure on Clinical Labs

February 15th, 2018 / Christine Valle

Molecular tests and antibiotic resistance detection sorely needed If you haven’t brushed up on emerging trends in sexually transmitted infections lately, don’t miss this MLO article from our own Anjana Bhattacharya. As she points out, “The landscape of sexually transmitted infections (STIs) has been shifting rapidly in recent years, with prevalence rates of certain STIs

Continue reading »

A Laboratory’s Perspective: How Ascension/St. John Providence Manages Seasonal Testing Demands

February 8th, 2018 / Scott Henderson

Recently, Luminex spent time with Dr. Ted E. Schutzbank, Technical Director of the Specialized Testing and Microbiology Laboratory at St. John Providence, part of Ascension. Dr. Schutzbank recounted that with breadth of samples, also comes varying degrees of urgency to deliver answers. This challenge requires the lab to operate with the utmost of efficiency, while

Continue reading »

Webinar Wednesday: Brian McFarlin, Ph.D., from the University of North Texas

February 7th, 2018 / Hilary Graham

Detection of Pre-Clinical Disease Risk using Multiplex Serum Biomarker This year, we’re launching Webinar Wednesday – a day dedicated to sharing diverse work of the xMAP® multiplexing community. We’ll highlight pre-recorded webinars from the xMAP Connect users group meetings in Boston and Amsterdam, as well as live webinars featuring xMAP enthusiasts, Luminex field application scientists, and

Continue reading »

The Faces of Luminex: Wojciech Swidzinski, Field Applications

February 2nd, 2018 / Christine Valle

When Luminex customers in Europe, the Middle East, India, or Africa have technical questions about their instruments, they may get help from Wojciech Swidzinski. As Senior Field Applications Specialist, EMEIA, he helps train new customers and solves problems for existing customers. He earned his master of sciences in engineering in biotechnology from Warsaw University for

Continue reading »

Meet Myriad RBM

January 30th, 2018 / Hilary Graham

Offering comprehensive protein biomarker services for over 300 targets Myriad RBM, Inc. is the world’s leading multiplexed immunoassay development and testing laboratory. They are also the first Luminex Partner. We recently visited their site in Austin, Texas, to learn how they partner with biotechnology, pharmaceutical, and academic sponsors to support biomarker testing for clinical trials. Myriad

Continue reading »

California Hospital System Uses VERIGENE® System to Address Antibiotic Resistance

January 25th, 2018 / Christine Valle

Rapid detection leads to informed treatment decisions Palomar Health was recently profiled by VigiLanz for its work to address the crisis of antibiotic resistance. Its platform of choice is the VERIGENE® System for rapid blood culture diagnostics. The healthcare system, based in California, operates three hospitals and several other facilities. According to the profile, “Palomar

Continue reading »